Articles tagged with Rheumatoid Arthritis
The Vectra DA algorithm provides a robust molecular monitoring system for RA disease activity. Studies show it can predict progressive joint damage and is robust in patients with common comorbid conditions.
A recent study published in Nature Immunology has discovered a novel mechanism by which tumor necrosis factor (TNF) suppresses inflammatory responses. The researchers found that TNF activates the glycogen synthase kinase 3-alpha protein and upregulates the A20 gene, leading to reduced inflammation.
A systematic review found that t'ai chi is effective for fall prevention and improving psychological health, with general health benefits for older people. However, its effectiveness for other conditions such as cancer and rheumatoid arthritis is contradictory.
Researchers at NYU Langone Medical Center created a novel protein molecule derived from progranulin, which may offer alternative treatments for chronic inflammatory diseases like rheumatoid arthritis. The protein has been shown to have a high affinity and specificity for binding to tumor necrosis factor receptors.
A recent trial found the combination of rituximab, a TNF inhibitor, and methotrexate showed a consistent safety profile for rheumatoid arthritis patients. While no new safety concerns were identified, clear efficacy benefits were not observed in this study sample.
A study of 162 RA patients found poor sleep quality correlated with higher depressive symptoms, increased fatigue, and greater functional disability. Addressing sleep problems may have a critical impact on the health and lives of patients with RA.
Researchers redefine remission in rheumatoid arthritis by introducing two new provisional definitions that aim to standardize treatment goals. The new definitions focus on disease activity measures, including tender joint count, swollen joint count, and C-reactive protein levels.
A Stanford researcher's study reveals that many rheumatoid arthritis patients are not receiving recommended disease-modifying antirheumatic drugs (DMARDs) due to high costs and health disparities. The study found that 63% of Medicare-managed care patients received any DMARD treatment, with significant variations by income level, race, ...
A study of over 90,000 Medicare managed care patients with rheumatoid arthritis found significant variations in the receipt of recommended medications. Demographic factors such as age, sex, race, socioeconomic status, and geographic location played a role in determining medication use.
In a phase II trial, fostamatinib disodium, an oral spleen tyrosine kinase inhibitor, failed to demonstrate efficacy in patients with rheumatoid arthritis who had not responded to biologic agents. However, the drug was found to be safe and showed promise in subgroups of patients with elevated C-reactive protein levels.
A recent study found that low socioeconomic status is associated with higher rates of depressive symptoms in RA patients. Researchers analyzed data from 466 patients and found significant disparities in mental health outcomes between those with high and low SES.
Researchers estimate lifetime risk of rheumatoid arthritis for both sexes using data from the Rochester Epidemiology Project. The study finds that 8.4% of women and 5.1% of men will develop an inflammatory autoimmune disease in their lifetime.
Current smokers with early rheumatoid arthritis showed reduced response to treatment with methotrexate and tumor necrosis factor inhibitors. The study found that smoking history did not impact the effectiveness of these therapies.
Research published in Annals of the Rheumatic Diseases found that smoking is a major preventable risk factor for rheumatoid arthritis, accounting for over 35% of ACPA positive cases and one in five cases overall. Heavy smokers are more than 2.5 times as likely to test positive for ACPA.
A large-scale study found that patients with rheumatoid arthritis have a 60% higher risk of heart attack just one year after diagnosis, with the risk increasing rapidly in the first few years. The study emphasizes the importance of monitoring heart risk from the moment RA is diagnosed.
A recent study published in Arthritis & Rheumatism found that early diagnosis and treatment with disease-modifying antirheumatic drugs (DMARDs) can significantly improve outcomes for patients with rheumatoid arthritis. Delayed treatment was associated with increased joint destruction and lower chances of achieving DMARD-free remission.
African Americans who smoke cigarettes have a higher risk of developing rheumatoid arthritis (RA), with heavy smokers at greatest risk. The study found that limiting cumulative smoking exposure to less than 10 pack-years could prevent roughly one in six new cases of RA.
Researchers found that homeopathic consultations can significantly reduce symptoms of rheumatoid arthritis when combined with conventional treatment. The benefits were attributed to the consultation process, not the remedies used.
Researchers have discovered that mesenchymal stem cells from umbilical cord blood can suppress inflammation and attenuate collagen-induced arthritis. The study suggests a new potential therapy for rheumatoid arthritis, which currently has limited long-term drug-free remission options.
The study found significant benefits of Tai Chi for individuals with arthritis, including improved pain, fatigue, stiffness, and sense of well-being. Participants showed moderate improvements in physical function performance measures, such as timed chair stands and gait speed.
A new study suggests that bortezomib, a proteasome inhibitor, reduces disease severity and inflammation in an animal model of inflammatory arthritis. The drug promotes bone healing and displays favorable effects in targeting critical cell populations involved in the development of RA.
A meta-analysis of 70 randomized trials found that disease-modifying antirheumatic drugs (DMARDs) and glucocorticoids significantly reduced radiographic joint destruction, similar to biologic agents. Combination therapies also showed promise in reducing structural damage.
Researchers discovered a significant association between persistent statin use and reduced incidence of rheumatoid arthritis, compared to non-users. After adjusting for confounders, patients who used statins persistently had a lower risk ratio of developing rheumatoid arthritis, with no significant short-term effect.
Researchers have created a new animal model for rheumatoid arthritis that closely mimics the human disease. The KRN-CTM model exhibits chronic inflammation and cartilage damage similar to human cases.
A study by the University of South Florida found that the rheumatoid arthritis signaling protein GM-CSF reduces AD pathology and eliminates memory loss in mice. The researchers suggest that GM-CSF boosts immune cells to remove Alzheimer's plaques, improving memory decline.
Researchers found that gene variants associated with type-1 diabetes and rheumatoid arthritis confer previously unknown benefits to their human carriers. This suggests that the human race may be evolving towards greater susceptibility to complex diseases.
The new criteria redefine RA by classifying it based on the confirmed presence of synovitis in at least one joint, absence of alternative diagnoses, and a combined score from four domains. Early diagnosis and treatment can prevent destructive joint damage with the help of synthetic and biological disease-modifying antirheumatic drugs.
The American College of Rheumatology has announced revised classification criteria for rheumatoid arthritis, allowing researchers to study patients earlier in the course of the disease. The new criteria aim to prevent joint damage and improve patient outcomes.
Researchers have discovered that ROCK2 protein is involved in regulating the production of IL-17 and IL-21, which are linked to autoimmunity. Administration of a ROCK inhibitor has shown promise in reducing disease symptoms and ameliorating conditions in mice models.
A new study published in Rheumatology found that moderate alcohol consumption may reduce the severity of rheumatoid arthritis symptoms and risk. The study, which involved over 1,800 patients, showed a significant inverse association between frequency of alcohol consumption and RA severity.
Researchers found that regular aerobic exercise improves function, lessens joint pain, and increases quality of life in patients with stable rheumatoid arthritis. The study analyzed 14 studies and meta-analysis included 510 patients, showing that cardio-respiratory conditioning is safe and beneficial for this group.
Researchers found that patients treated with early combination disease-modifying antirheumatic drug therapy had less radiographic damage in small joints, even after 11 years. Early and aggressive treatment achieves excellent results for most patients, especially those who achieve strict remission at 1 year.
A study of 356 RA patients found that achieving disease remission leads to significant improvements in work productivity, quality of life, and physical functioning compared to low disease activity. Longitudinal analysis over one year showed stable emotional aspects and significant reductions in overall activity impairment.
A UK study reveals that partners of RA patients experience common issues such as emotions and adaptation to the diagnosis. The research highlights the importance of offering support to partners at the time of diagnosis, which can lead to improved emotional outcomes for both parties.
A new study reveals that rheumatoid arthritis (RA) patients have a two-fold increased risk of myocardial infarction (MI), comparable to diabetes patients. The risk is particularly high in young women with RA, increasing six-fold for those under 50 years old.
A multinational study found that patients in rich countries are three times more likely to receive biologic treatments for rheumatoid arthritis than those in poor countries. The study also showed no impact of macro-economic status on RA patients' perceptions of disease severity, measured by patient-reported outcomes.
A study found that the presence of Breast Cancer Resistance Protein (BCRP) in rheumatoid arthritis (RA) patients may indicate higher disease activity and create a barrier to DMARDs. BCRP was detected in 41% of RA patient samples, suggesting it could be a predictive marker for treatment resistance.
A US-based longitudinal cohort study found a positive association between incident RA and increasing tea consumption, with women who drank ≥4 cups of tea per day having a significantly increased risk. No correlation was found between coffee consumption and RA incidence.
Studies from France and Brazil reveal that rheumatic conditions like RA and SLE significantly impact emotional relationships and sexual activity, with many patients unwilling to seek help. Patients often experience physical problems such as decreased libido and joint pain, as well as emotional consequences like guilt and frustration.
A multinational study has validated previous research showing NT-proBNP is a strong indicator for cardiovascular risk in arthritis patients. Early control of inflammation can help manage long-term CV risk associated with RA. Elevated inflammatory markers like CRP are also independent predictors of CV risk.
Studies show smoking predicts RA diagnosis and poor response to anti-TNFs, altering gene expression and immune response. Swedish studies confirm smoking risk for RA, while mouse models reveal similar changes in human cells.
A new study found that 72% of women with RA experience daily physical pain, affecting emotional and social aspects of their lives. The study highlights the importance of reducing pain in managing RA and improving patients' productivity at work.
A new study found that alcohol consumption is associated with a reduced risk of developing several arthritic conditions. However, the exact nature of this association remains unclear, with some researchers suggesting that moderate alcohol consumption may protect against systemic inflammation.
A recent study found a significant rise in rheumatoid arthritis incidence among women between 1995 and 2007. Researchers attribute the increase to environmental factors such as vitamin D deficiency, cigarette smoking, and lower-dose synthetic estrogens in oral contraceptives.
A study found that nearly one-third of RA patients and their physicians disagreed on assessing the disease severity. The disagreement was most prevalent in patients with depressive symptoms or poor overall function.
A recent study by Boston University School of Public Health researchers found a strong association between vitamin D deficiency and an increased risk of rheumatoid arthritis in women. The study, which analyzed data from the Nurses' Health Study, suggests that higher latitudes may lead to lower levels of vitamin D due to reduced sunligh...
Scientists at NYU Langone Health discovered a potential new target for treating rheumatoid arthritis by boosting the normal activity of regulatory T cells, which counterbalance conventional T cells' hyperactivity. The study reveals how an investigational drug wards off inflammation by holding an enzyme at bay.
Researchers at the University of Leicester have made a new discovery about how the body fights certain types of cancer and autoimmune diseases. A newly discovered protein, HVCN1, regulates antibody production and can be targeted for therapies to treat conditions like lupus and rheumatoid arthritis.
Research found fluoxetine (Prozac) and citalopram (Celexa) significantly inhibited disease progression of collagen-induced arthritis in mice. The study suggests potential drug development opportunities for arthritic conditions like rheumatoid arthritis.
Researchers used contrast-enhanced MRI to differentiate between rheumatoid arthritis and psoriatic arthritis, finding a significant difference in perfusion after 15 minutes. The study suggests that contrast-enhanced MRI could play a key role in targeted therapies for each condition.
Researchers have identified several cytokines that increase significantly prior to rheumatoid arthritis disease onset, indicating immune system activation. Early diagnosis and treatment may prevent disease progression and improve quality of life for patients.
A researcher from Northwestern University has invented a novel way to halt and reverse rheumatoid arthritis by developing an imitation of a suicide molecule that targets hyperactive immune cells. The approach, tested on mice, showed promising results with a 75% success rate and no reported toxicity.
Researchers found that touch typing training significantly improved keyboarding speed in RA workers, regardless of impairment. However, impairments in hand function were associated with reduced mouse speeds, highlighting the need for effective strategies to maintain productivity in computer users with RA.
Researchers found that RA patients treated with rituximab are partially protected by the influenza vaccine, but its effectiveness is drastically reduced in the first 6 months following treatment. The study's results suggest that RA activity was not influenced by the flu vaccine administration.
Researchers found that RA patients treated with rituximab in combination with methotrexate had the same immune response to the tetanus vaccine as those treated with methotrexate alone. However, patients on rituximab had a reduced response to the pneumonia vaccine compared to those on methotrexate alone.
BG-12, an investigational oral therapy, shows promising results in reducing inflammation and neuroprotection in patients with relapsing-remitting multiple sclerosis (RRMS) and rheumatoid arthritis (RA). The compound has activated the Nrf2 pathway, which defends against oxidative-stress induced neuronal death and supports myelin integrity.
Researchers found that chicken type II collagen (CCII) capsules improved joint function in RA patients with fewer side effects compared to the established antirheumatic drug methotrexate. Oral tolerance induction via dietary exposure is believed to contribute to this finding.
Family health history disclosure may not improve clinical decision making, according to researchers. Meanwhile, community-based interventions in developing countries have been shown to effectively reduce blood pressure. Early treatment of rheumatoid arthritis may also benefit from conventional DMARD therapy or biologics, but their cost...
A recent study by Swedish researchers found that rheumatoid arthritis (RA) patients taking anti-tumor necrosis factor (TNF) therapy did not experience an elevated cancer risk. The study included data from 6,366 patients and compared their cancer risk to those who were not taking TNF inhibitors or using other immunosuppressant drugs.
Research found inflammation is associated with increased pain sensitivity at joint sites, while sleep problems are linked to increased pain sensitivity at both joint and non-joint sites. This study highlights the importance of considering inflammatory and non-inflammatory factors when evaluating pain in RA patients.